| 标题 |
Cost Effectiveness of the First‐in‐Class ARNI (Sacubitril/Valsartan) for the Treatment of Essential Hypertension in a Chinese Setting |
| 网址 | |
| DOI | |
| 其它 |
期刊:PharmacoEconomics 作者:Xinyue Dong; Xiaoning He; Jing Wu 出版日期:2022-09-08 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)